Fumiko Ito

Phase II Clinical Trial of Lenalidomide and Dexamethasone Therapy in Japanese Elderly Patients With Newly Diagnosed Multiple Myeloma to Determine Optimal Plasma Concentration of Lenalidomide

N. Takahashi, M. Miura, T. Niioka, 2018, Therapeutic drug monitoring.

The BCRP inhibitor febuxostat enhances the effect of nilotinib by regulation of intracellular concentration

N. Takahashi, M. Miura, Y. Kameoka, 2020, International Journal of Hematology.

Effect of low platelet HLA-C expression on donor-specific antibody depletion following platelet transfusion from a corresponding HLA donor

N. Takahashi, M. Nara, N. Fujishima, 2019, Bone Marrow Transplantation.

Influence of ABCB1 polymorphisms on the pharmacokinetics and toxicity of lenalidomide in patients with multiple myeloma

N. Takahashi, M. Miura, Y. Akamine, 2019, Medical Oncology.